CDC authorizes COVID-19 vaccines for children 5-11 years of age

Image of GettyImages-1315887649.jpg

Key Takeaways

On November 2, the Centers for Disease Control and Prevention (CDC) approved the use of COVID-19 vaccines for children aged 5-11 following the Food and Drug Administration’s (FDA) recommendation. The CDC’s endorsement follows the FDA’s recommendation on October 29 to authorize emergency use of the Pfizer-BioNTech COVID-19 vaccine to include children 5-11 years of age.

The FDA’s decision comes after it was determined the vaccine was approximately 91 percent effective in preventing COVID-19 in children 5-11 years of age. Children within this age group account for 39 percent of COVID-19 cases in individuals younger than 18 years of age across the nation. An ongoing study discovered no serious side effects in approximately 3,100 children aged 5-11 who received the COVID-19 vaccine.

On October 14, the CDC released a Pediatric COVID-19 Vaccination Operational Planning Guide, which highlights key differences between adult and adolescent vaccination programs and those that are designed for children. The National Association of County and City Health Officials (NACCHO) has provided a summary of the guide and pulled out high-level considerations for county health departments, as key components of pediatric COVID-19 vaccination planning in local communities.

As key providers of local public health services and frontline service providers for the medically vulnerable, counties have supported over 192 million vaccinations in the United States to date and will continue to play an essential role in the administration of COVID-19 vaccines and boosters. For more information on how county health facilities can prepare for the distribution of COVID-19 vaccines for children, and COVID-19 boosters, see NACo’s COVID-19 Vaccine Distribution Toolkit.

ADDITIONAL RESOURCES

Tagged In:

Related News

Medicaid
Press Release

State and Local Government Organizations Express Concern Over Proposed Changes to Medicaid Financing and Requirements

NACo, NLC, NCSL, USCM, CSG and ICMA emphasize the impact of policy changes to eligibility requirements and financing of Medicaid.

Image of Capitol-closeup-4.jpg
Advocacy

U.S. Congress begins work on budget reconciliation process: What this means for counties

The House and Senate Budget Committees have marked up Fiscal Year (FY) 2025 budget resolutions to initiate the budget reconciliation process to enact policy priorities without garnering bipartisan support, although the two chambers differ in their approach to drafting the legislation. 

Doctor and patient
Advocacy

Congress introduces bipartisan legislation to strengthen rural health care access and funding

Rural communities face unique health care challenges, from provider shortages to funding disparities. To address these concerns, the U.S. Senate recently introduced two bipartisan bills aimed at improving rural health care access and funding: the Rural Health Focus Act and the Fair Funding for Rural Hospitals Act.